| 書目名稱 | Predictive Biomarkers in Oncology |
| 副標(biāo)題 | Applications in Prec |
| 編輯 | Sunil Badve,George Louis Kumar |
| 視頻video | http://file.papertrans.cn/755/754580/754580.mp4 |
| 概述 | The first single source on this subject to put all this evidence together in a concise and easy to understand manner..Uniquely formatted with sidebars, special interest boxes and illustrations..Provid |
| 圖書封面 |  |
| 描述 | ? “Precision/personalized or stratified medicine” refers to the tailoring of medical treatment or drug administration to the individual characteristics of each patient treatment. It does not literally mean that a pharmaceutical company makes a drug for an individual patient for consumption and treatment but rather means the ability to stratify (or classify) individuals into sub-populations that differ in their responsiveness to a specific drug. A marker that provides information on the likely response to therapy, i.e., either in terms of tumor shrinkage or survival of the patient is termed “predictive biomarker”.?Despite their promise in precision medicine and the explosion of knowledge in this area, there is not a single source on this subject that puts all this evidence together in a concise or richly illustrated and easy to understand manner..? This book provides a collection of ingeniously organized, well-illustrated and up-to-date authoritative chapters divided into five sections that are clear and easy to understand. Section one provides an overview of biomarkers, introduces the basic terminologies, definitions, technologies, tools and concepts associated with this subject in |
| 出版日期 | Book 2019 |
| 關(guān)鍵詞 | Kaplan Meier; RECIST; Immunohistochemistry; Liquid biopsy; Databases of Biomarkers; biomarker assessment |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-319-95228-4 |
| isbn_ebook | 978-3-319-95228-4 |
| copyright | Springer Nature Switzerland AG 2019 |
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-9 12:26
發(fā)表于 2025-3-21 17:11:09
